Compare

Propanc Biopharma, Inc. vs NRX Pharmaceuticals, Inc. vs Imunon, Inc. vs Turn Therapeutics Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPropanc Biopharma, Inc.
PPCB
NRX Pharmaceuticals, Inc.
NRXP
Imunon, Inc.
IMNN
Turn Therapeutics Inc.
TTRX
Year ended2026-06-302025-12-312025-12-312025-12-31
Revenuen/a$1.45Mn/an/a
Revenue growth (YoY)n/an/an/an/a
Gross marginn/a65.1% (computed)n/an/a
Operating marginn/an/mn/an/a
Net marginn/an/mn/an/a
Net income-$18.86M-$28.62M-$14.50M-$3.19M
EPS (Diluted)-$17.62n/a-$6.83-$0.12
Operating cash flow-$5.68M-$14.11M-$13.90M-$2.56M
Free cash flow-$5.69Mn/a-$14.18Mn/a
Cash & equivalentsn/a$7.80M$8.78M$4.03M
Total assets$12.78M$12.96M$12.29M$12.16M
Total liabilities$3.38M$28.89M$5.23M$7.48M
Shareholders' equity$9.40M-$15.94M$7.06M$4.69M
Return on year-end equity-200.6%n/a-205.3%-68.2%
Shares outstanding3.31M31.73M3.42M29.45M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPropanc Biopharma, Inc.NRX Pharmaceuticals, Inc.Imunon, Inc.Turn Therapeutics Inc.
Latestn/a$1.45M
Ended 2025-12-31
$500.0K
Ended 2022-12-31
n/a
1 year earliern/a$0
Ended 2024-12-31
$500.0K
Ended 2021-12-31
n/a
2 years earliern/a$0
Ended 2023-12-31
$500.0K
Ended 2020-12-31
n/a
3 years earliern/an/a$500.0K
Ended 2019-12-31
n/a
4 years earliern/an/a$500.0K
Ended 2018-12-31
n/a